Study guide

11.2 MNT in Oncology: Cancer Cachexia and Treatment Side Effects

Nutritionist-Dietitian Licensure Examination NDLE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Licensure Law, Ethics, and the Clinical Nutritionist-Dietitian

1.1 NDLE Format, Scoring Rules, and RA 10862 Licensure Requirements 1.2 Scope of Practice, Professional Ethics, and Discipline under RA 10862 1.3 Role of the Clinical Nutritionist-Dietitian, Diet Orders, and Standard Hospital Diets

2 Chapter 2: Anatomy and Physiology for Nutrition I

2.1 Cells, Tissues, Membranes, and the Immune and Lymphatic Systems 2.2 The Digestive System: Organs, Enzymes, GI Hormones, and the Liver 2.3 Endocrine and Nervous System Regulation of Metabolism and Appetite

3 Chapter 3: Anatomy and Physiology II, Energy, and Carbohydrate Metabolism

3.1 Cardiovascular, Respiratory, Renal, Musculoskeletal, and Reproductive Systems 3.2 Energy Metabolism and Energy Expenditure Calculations 3.3 Carbohydrate Chemistry, Digestion, and Glycemic Pathways

4 Chapter 4: Protein, Lipid, Mineral, and Fluid Biochemistry

4.1 Protein Chemistry, Amino Acid Metabolism, and Nitrogen Balance 4.2 Lipid Metabolism, Lipoproteins, and Cardiovascular Biomarkers 4.3 Minerals, Water, Electrolytes, and Acid-Base Balance

5 Chapter 5: Basic Nutrition: Vitamins, Minerals, and the PDRI

5.1 Vitamin Biochemistry: Coenzyme Functions and Deficiency Syndromes 5.2 Vitamins and Minerals: PDRI Values, Food Sources, Bioavailability, Stability, and Toxicity 5.3 Philippine Dietary Reference Intakes (PDRI 2015), Pinggang Pinoy, and Dietary Guidelines

6 Chapter 6: Diet Computation and Clinical Nutrition Assessment

6.1 Food Exchange Lists, Meal Plan Computation, Food Labels, and Nutrient Density 6.2 Computing Desirable Body Weight, Total Energy Requirement, and the Diet Prescription 6.3 ABCD Methods of Clinical Nutrition Assessment

7 Chapter 7: Nutrition Diagnosis, Life-Stage Assessment, and Laboratory Data

7.1 Nutrition Diagnosis, PES Statements, and Medical Record Documentation 7.2 Pediatric, Obstetric, and Geriatric Clinical Nutritional Assessment 7.3 Interpreting Biochemical and Laboratory Data in Nutrition Assessment

8 Chapter 8: Drug-Nutrient Interactions, Diabetes, and Weight Disorders

8.1 Drug-Nutrient Interactions and Nutrient Depletion 8.2 MNT for Diabetes Mellitus and Endocrine Disorders 8.3 MNT for Overweight, Obesity, and Underweight

9 Chapter 9: MNT for Cardiovascular, Renal, and Gastrointestinal Disease

9.1 MNT for Cardiovascular Disease, Hypertension, and Dyslipidemia 9.2 MNT for Renal Diseases (AKI, CKD Stages 1-5, Dialysis, and Nephrotic Syndrome) 9.3 MNT for Disorders of the Gastrointestinal Tract

10 Chapter 10: MNT for Liver, Infectious, Respiratory, Allergic, and Neurologic Conditions

10.1 MNT for Liver, Gallbladder, and Pancreatic Disorders 10.2 MNT for Fevers, Infections, Diarrheal Disease, and Respiratory Disorders 10.3 MNT for Food Allergy and Intolerance, Skin, Rheumatic, Musculoskeletal, and Neurologic Disorders

11 Chapter 11: Critical Illness, Oncology, HIV, and Protein-Energy Malnutrition

11.1 MNT in Critical Illness, Sepsis, Trauma, and Burns 11.2 MNT in Oncology: Cancer Cachexia and Treatment Side Effects 11.3 MNT for HIV/AIDS and for Protein-Energy Malnutrition in Children and Adults

12 Chapter 12: Metabolic Disorders, Dysphagia, and Enteral Nutrition

12.1 MNT for Inborn Errors of Metabolism and Eating Disorders 12.2 Dysphagia, IDDSI Texture-Modified Diets, and Adaptive Feeding 12.3 Enteral Nutrition: Indications, Formula Selection, Access Routes, and Complications

13 Chapter 13: Parenteral Nutrition, Refeeding, and Nutrition Counseling

13.1 Parenteral Nutrition: Indications, Access, Substrates, and Compounding 13.2 Refeeding Syndrome and Complications of Parenteral Nutrition 13.3 Nutrition Counseling and Behavior Change Theories

14 Chapter 14: Nutrition Updates: Supplements, Diet Trends, and Sports Nutrition

14.1 Dietary Supplements, Herbal Medicines, and Functional Foods 14.2 Vegetarian Diets, Protein Complementation, and Popular Diet Trends 14.3 Sports Nutrition and Workplace Wellness Programs

15 Chapter 15: Community Nutrition and Population Assessment

15.1 Community Nutrition Principles, the ND's Roles, and the Philippine Health Delivery System 15.2 Nutritional Epidemiology and Health Status Indicators in the Philippines 15.3 Assessment of Community Nutritional Status and Operation Timbang Plus (OPT+)

16 Chapter 16: Dietary Surveys, Nutrition Research, and Surveillance

16.1 Food Consumption Surveys, Biochemical Tests in Surveys, and Clinical Signs of Deficiency 16.2 Food and Nutrition Research Methods, Sampling, Sample Size, and Research Ethics 16.3 National Nutrition Surveys, Demographic Data, and Designing a Nutrition Surveillance System

17 Chapter 17: Nutrition Education and Program Evaluation

17.1 Nutrition Education: Definition, Principles of Learning, Methods, and Teaching Aids 17.2 Designing a Nutrition Education Program and Measuring Customer Satisfaction 17.3 Program Planning Cycle, SMART Objectives, and Types of Evaluation

18 Chapter 18: Program Planning, Interventions, and Food Security

18.1 Nutrition Program Planning: Needs, Priorities, Constraints, Goals, and Using Evaluation Results 18.2 Nutrition Interventions and Programs for Specific Population Groups 18.3 Food and Nutrition Security, Dietary Diversity, and Vulnerable Populations

19 Chapter 19: Nutrition Governance, Networking, and Program History

19.1 National Nutrition Council (NNC) Structure and Philippine Plan of Action for Nutrition (PPAN) 19.2 Nutrition Agencies, Networking, Community Linkages, Teamwork, and Nutrition Legislation 19.3 Development of Philippine Nutrition Programs and the Country's Nutrition Problems

20 Chapter 20: Fortification, Feeding, and First 1,000 Days Laws

20.1 Food Fortification (RA 8976), Salt Iodization (RA 8172), and the 2024 Salt Industry Law 20.2 Supplementary Feeding Programs (RA 11037) and DSWD/DepEd Interventions 20.3 First 1,000 Days Law (RA 11148) and Maternal-Child Interventions

21 Chapter 21: Nutrition in the Life Cycle I

21.1 Infant and Young Child Feeding (IYCF), Philippine Milk Code (EO 51), and RA 10028 21.2 Nutrition in Pregnancy and Lactation: Physiology, Needs, Meal Patterns, and Problems 21.3 Nutrition from Infancy to School Age: Growth, Feeding Patterns, Problems, and School Programs

22 Chapter 22: Nutrition in the Life Cycle II

22.1 Nutrition for Adolescents and Adults: Growth Spurt, Risk Factors, and NCD Prevention 22.2 Nutrition for Older Adults: Aging Changes, Needs, Problems, and Senior Citizen Programs

23 Chapter 23: Food Science and Plant Foods

23.1 Chemistry of Starches, Proteins, Lipids, and Emulsions in Cooking 23.2 Food Pigments, Flavor Chemistry, and Browning Reactions (Maillard & Enzymatic) 23.3 Fruits, Vegetables, and Legumes: Classification, Market Forms, Quality, Storage, and Cookery

24 Chapter 24: Animal Foods, Cereals and Baking, and Cooking Methods

24.1 Meat, Poultry, Fish, Eggs, and Milk: Structure, Quality, Storage, and Cookery 24.2 Cereals, Flour Mixtures and Baking, Sugar Cookery, Fats and Oils, and Beverages 24.3 Heat Transfer, Dry-Heat and Moist-Heat Cooking Methods, and Filipino Cooking Techniques

25 Chapter 25: Culinary Skills, Family Meal Planning, and Food Quality

25.1 Culinary Vocabulary, Knife Cuts, Basic Sauces, and Accurate Measurement 25.2 Meal Planning for the Family, Food Budgeting, and Recipe Development 25.3 Sensory Evaluation, Objective Food Tests, and Quality Assurance in Food Production

26 Chapter 26: Food Microbiology, Preservation, and Food Law

26.1 Foodborne Pathogens, Microbial Kinetics, and FAT TOM Parameters 26.2 Food Preservation Methods, Thermal Processing, and Packaging 26.3 Philippine Food Laws, Regulatory Agencies, and Food Labeling

27 Chapter 27: Sanitation, HACCP, Waste, and Workplace Safety

27.1 Sanitation Standard Operating Procedures (SSOP) and Good Manufacturing Practices (GMP) 27.2 HACCP Principles and Critical Control Point Management in Food Service 27.3 Waste Management, Pest Control Regulation, and Occupational Safety in Food Service

28 Chapter 28: Food Service Systems, Production Planning, and Menus

28.1 Types of Food Service Delivery Systems (Conventional, Ready-Prepared, Commissary, Assembly) 28.2 Forecasting, Production Planning, and Quantity Food Production Techniques 28.3 Institutional Menu Planning, Modified Diets, and Recipe Standardization

29 Chapter 29: Distribution, Purchasing, and Storage

29.1 Food Distribution and Service Systems in Hospitals and Other Institutions 29.2 Food Purchasing Methods, Specifications, and Receiving 29.3 Storage Management, Inventory Control, and Valuation

30 Chapter 30: Cost Control, Financial Management, and Facility Layout

30.1 Food Cost Accounting, Yield Testing, and Portion Control Formulas 30.2 Menu Pricing Models, Break-Even Analysis, and Financial Statements 30.3 Food Service Facility Layout, Equipment Selection, and Workflow Ergonomics

31 Chapter 31: Equipment, Management, and Human Resources

31.1 Food Service Equipment: Selection, Capacity, Life-Cycle Cost, Depreciation, and Maintenance 31.2 Management Functions, Theories, Leadership Styles, and Managing Change in Food Service 31.3 Human Resource Management: Job Design, Recruitment, Training, Appraisal, and Discipline

32 Chapter 32: Labor Law, Permits, and Food Service Marketing

32.1 Philippine Labor Laws and Business Permits for Food Service Operations 32.2 Food Service Marketing, Menu Engineering, and Sustainable Food Service

11.2 MNT in Oncology: Cancer Cachexia and Treatment Side Effects

Key Takeaways Explain This Topic AI

Cancer cachexia is a multifactorial metabolic syndrome driven by pro-inflammatory cytokines (TNF- α \alpha α , IL-1, IL-6, IFN- γ \gamma γ ) that triggers uncoupling protein activation, accelerated lean mass proteolysis, and futile substrate cycling refractory to conventional nutrition support alone.

International consensus defines cachexia as more than 5% weight loss in 6 months, or more than 2% weight loss in people already depleted (BMI below 20 or sarcopenia), and stages it as precachexia, cachexia, and refractory cachexia.

Ambulatory cancer patients generally need 25-30 kcal/kg/day and 1.0-1.2 g protein/kg; hypermetabolic or depleted patients need 30-35 kcal/kg/day and up to 1.2-2.0 g protein/kg.

Mucositis calls for soft, moist, bland, non-acidic foods at room temperature, while metallic dysgeusia improves with plastic utensils and tart or sweet marinades.

Last updated: October 2026

In advanced clinical practice and the Nutritionist-Dietitian Licensure Examination (NDLE) , clinical dietitians must differentiate between uncomplicated starvation and hypermetabolic, cytokine-driven stress states. While simple starvation induces adaptive hypometabolism that conserves somatic protein through ketone utilization, hypermetabolic conditions—such as advanced malignancies, septic shock, systemic inflammatory response syndrome (SIRS), and severe thermal burns—trigger neuroendocrine and immune cascades that accelerate lean body mass proteolysis, alter substrate utilization, and elevate resting energy expenditure.

Cancer Cachexia Syndrome

Cancer cachexia is a multifactorial metabolic syndrome characterized by an involuntary, progressive loss of skeletal muscle mass (with or without loss of adipose tissue) that cannot be fully reversed by conventional nutritional support alone, leading to progressive functional impairment. Pro-Inflammatory Cytokines

  • (TNF-alpha, IL-1, IL-6, IFN-gamma)
  • Tumor-Derived Proteolysis Factors
  • │
  • ┌────────────────────────────┼────────────────────────────┐
  • ▼ ▼ ▼
  • [Skeletal Muscle] [Adipose Tissue] [Systemic Metabolism]
  • Ubiquitin-proteasome - Lipolysis via HSL/ATGL - UCP-1/2/3 upregulation
  • pathway activated - Free fatty acid release (mitochondrial uncoupling)
  • Proteolysis > synthesis - Adipocyte browning - Futile Cori cycle (liver)
  • Sarcopenia / weakness - Severe fat atrophy - Hypermetabolism / fatigue
  • Pathophysiologic Mediators and Metabolic Derangements

Unlike simple starvation, cancer cachexia is driven by systemic chronic inflammation and tumor-host interactions:

Pro-Inflammatory Cytokines: Tumor cells and host immune cells secrete high concentrations of Tumor Necrosis Factor-alpha (TNF- α \alpha α / cachectin) , Interleukin-1 (IL-1) , Interleukin-6 (IL-6) , and Interferon-gamma (IFN- γ \gamma γ ) .

TNF- α \alpha α suppresses appetite via hypothalamic signaling and stimulates the breakdown of muscle and fat.

IL-6 drives the hepatic acute-phase response, stimulating production of C-reactive protein (CRP), fibrinogen, and ferritin while suppressing negative acute-phase proteins (albumin, prealbumin, transferrin).

Ubiquitin-Proteasome Proteolysis: Tumor-derived factors, such as Proteolysis-Inducing Factor (PIF) , activate the ATP-dependent ubiquitin-proteasome pathway in skeletal myocytes. Muscle proteins are tagged with ubiquitin and systematically degraded into free amino acids (alanine and glutamine) for hepatic gluconeogenesis.

Accelerated Lipolysis and Adipocyte Browning: Lipid-Mobilizing Factor (LMF) activates hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL), mobilizing free fatty acids and glycerol. Cytokines promote the "browning" of white adipose tissue, elevating expression of Uncoupling Proteins (UCP-1 in adipose tissue, UCP-2/3 in muscle) . These mitochondrial carrier proteins uncouple oxidative phosphorylation from ATP generation, dissipating the proton gradient as heat and accelerating energy expenditure through futile substrate cycling .

The Cori Cycle Burden: Malignant tumor cells depend heavily on anaerobic glycolysis even in the presence of oxygen ( the Warburg effect ). They convert glucose into lactate, which enters the circulation and travels to the liver. Hepatic gluconeogenesis recycles lactate back to glucose via the Cori cycle at an energetic cost of 6 ATP molecules per cycle , exhausting host energy reserves.

Diagnostic Stages of Cancer Cachexia

According to international consensus criteria, cachexia progresses through three clinical stages:

Precachexia: Weight loss ≤ 5 % \le 5\% ≤ 5% over 6 months, accompanied by anorexia and systemic inflammation/metabolic changes.

Cachexia: Weight loss > 5 % >5\% > 5% over 6 months (in the absence of simple starvation), OR weight loss > 2 % >2\% > 2% in individuals already depleted (BMI < 20 kg/m 2 <20\text{ kg/m}^2 < 20 kg/m 2 or skeletal muscle sarcopenia).

Refractory Cachexia: Severe catabolic state driven by advanced, rapidly progressive malignancy unresponsive to anticancer therapy; performance status is severely impaired (ECOG 3–4), and expected survival is < 3 months <3\text{ months} < 3 months . At this stage, aggressive artificial nutrition is generally burdensome and non-beneficial; care shifts toward palliative comfort.

Nutritional Symptom Management in Cancer Care

Chemotherapy, radiation therapy, and surgical resection induce secondary nutritional impact symptoms that severely limit nutrient intake:

Symptom / Impact Etiological Factors Clinical Dietetic Interventions

Anorexia & Early Satiety Cytokines, delayed gastric emptying, tumor compression Provide small, frequent, nutrient-dense meals (6–8 feedings daily); consume oral nutrition supplements (ONS) between meals rather than with meals; schedule primary caloric intake during morning hours when appetite peaks; avoid low-calorie liquids during meals.

Dysgeusia & Metallic Taste Chemotherapy (cisplatin, cyclophosphamide), zinc deficiency Use non-metallic (plastic) cutlery and glassware; marinate poultry and meats in tart citrus juices, sweet dressings, or fruit sauces; serve foods cold or at room temperature to reduce volatile aroma triggers; mask metallic flavors with mints, lemon drops, or chewing gum.

Mucositis & Stomatitis Cytotoxic destruction of oral mucosal epithelium Offer soft, moist, non-acidic, bland foods (purees, custards, puddings, scrambled eggs); avoid rough, crunchy, spicy, salty, or citrus foods; serve foods at room temperature or chilled; maintain gentle oral hygiene with alcohol-free rinses; consider topical oral glutamine suspensions.

Xerostomia (Dry Mouth) Head/neck radiation destroying salivary glands Moisten dry foods with gravies, broths, sauces, melted butter, or extra dressings; consume frequent sips of water or tart citrus beverages (if mucosa intact) to stimulate saliva; utilize sugar-free sour candies or artificial saliva sprays before meals.

Nausea & Vomiting Chemotherapy emetogenicity, vestibular disturbance Administer antiemetics 30–60 minutes prior to meals; offer dry, bland carbohydrates (crackers, pretzels, dry toast) upon waking; avoid greasy, fried, excessively sweet, or strongly aromatic foods; separate solids and liquids by 30–60 minutes.

Energy and Protein Prescriptions

Energy Requirements:

Non-stressed, ambulatory cancer patients: 25 to 30 kcal/kg/day 25\text{ to }30\text{ kcal/kg/day} 25 to 30 kcal/kg/day

Hypermetabolic, catabolic, or repletion patients: 30 to 35 kcal/kg/day 30\text{ to }35\text{ kcal/kg/day} 30 to 35 kcal/kg/day

Protein Requirements:

Maintenance in cancer: 1.0 to 1.2 g/kg/day 1.0\text{ to }1.2\text{ g/kg/day} 1.0 to 1.2 g/kg/day

Hypercatabolic wasting, active treatment, or cachexia repletion: 1.2 to 2.0 g/kg/day 1.2\text{ to }2.0\text{ g/kg/day} 1.2 to 2.0 g/kg/day

Neutropenic Precautions and Food Safety

When bone marrow suppression lowers the Absolute Neutrophil Count (ANC) below 500 / μ L 500/\mu\text{L} 500/ μ L (or < 1,000 / μ L <1{,}000/\mu\text{L} < 1 , 000/ μ L with an anticipated nadir), patients become highly vulnerable to opportunistic foodborne pathogens. Clinical dietitians must enforce strict low-microbial food safety protocols:

Eliminate Raw/Undercooked Animal Proteins: Avoid raw or runny eggs (cook until yolk and white are solid), rare/medium meats, sushi, sashimi, raw shellfish, and unpasteurized smoked seafood.

Eliminate Unpasteurized Dairy & Soft Cheeses: Prohibit raw milk and unpasteurized cheeses, including soft mold-ripened and blue-veined cheeses (brie, camembert, roquefort, gorgonzola, feta).

Produce Handling: Thoroughly wash and peel fresh fruits and vegetables; avoid fresh raw salads, raw sprouts (alfalfa, bean sprouts), and unpasteurized fruit juices or ciders.

Avoid High-Risk Venues: Prohibit food consumption from buffets, salad bars, street food stalls, and open delicatessens.

Water Safety: Use commercially bottled water or municipal water boiled vigorously for at least one minute.